Free Trial
Tada emoji MarketBeat All Access — Now Just $5.00 for 5 Weeks

Eyepoint Pharmaceuticals (EYPT) SEC Filings & 10K Form

Eyepoint Pharmaceuticals logo
$11.60 -0.24 (-2.03%)
Closing price 08/28/2025 04:00 PM Eastern
Extended Trading
$11.78 +0.18 (+1.52%)
As of 08/28/2025 06:36 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Eyepoint Pharmaceuticals SEC Filings

Export to Excel
DateFilerForm TypeView
08/12/2025
8:07 AM		Adage Capital Management, L.P. (Filed by)
Eyepoint Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
08/06/2025
6:05 AM		Eyepoint Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/29/2025
8:35 AM		Eyepoint Pharmaceuticals (Filer)
Form 8-K/A
07/29/2025
6:05 AM		Eyepoint Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/11/2025
3:06 PM		Duker Jay S. (Reporting)
Eyepoint Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2025
3:06 PM		Eyepoint Pharmaceuticals (Issuer)
Lurker Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2025
3:07 PM		Eyepoint Pharmaceuticals (Issuer)
Zaderej Karen L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2025
6:30 AM		Eyepoint Pharmaceuticals (Subject)
FEDERATED HERMES, INC. (Filed by)
FEDERATED HERMES, INC. (Filed by)
Form SCHEDULE 13G/A
06/25/2025
4:13 PM		Duker Jay S. (Reporting)
Eyepoint Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2025
6:05 AM		Eyepoint Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/27/2025
6:05 AM		Eyepoint Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2025
3:06 PM		Eyepoint Pharmaceuticals (Issuer)
Zaderej Karen L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2025
6:05 AM		Eyepoint Pharmaceuticals (Filer)
Form DEFA14A
05/07/2025
6:05 AM		Eyepoint Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/28/2025
3:10 PM		Eyepoint Pharmaceuticals (Filer)
Form DEFA14A
03/20/2025
3:06 PM		Duker Jay S. (Reporting)
Eyepoint Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
3:05 PM		Eyepoint Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/05/2025
6:05 AM		Eyepoint Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2025
8:00 AM		Eyepoint Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
5:37 PM		Eyepoint Pharmaceuticals (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SCHEDULE 13G/A
02/12/2025
8:33 AM		Adage Capital Management, L.P. (Filed by)
Eyepoint Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
02/11/2025
5:19 PM		Duker Jay S. (Reporting)
Eyepoint Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2025
5:19 PM		Eyepoint Pharmaceuticals (Issuer)
Lurker Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2025
5:19 PM		Elston George (Reporting)
Eyepoint Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
6:05 AM		Eyepoint Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/27/2025
11:58 AM		Eyepoint Pharmaceuticals (Subject)
FRANKLIN RESOURCES INC (Filed by)
Form SCHEDULE 13G/A
01/13/2025
6:05 AM		Eyepoint Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2025
3:11 PM		Eyepoint Pharmaceuticals (Issuer)
Sanders Reginald J. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/08/2025
3:14 PM		Eyepoint Pharmaceuticals (Issuer)
Sanders Reginald J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
6:05 AM		Eyepoint Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2025
3:03 PM		Duker Jay S. (Reporting)
Eyepoint Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
3:04 PM		Eyepoint Pharmaceuticals (Issuer)
Landis John B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
3:04 PM		Eyepoint Pharmaceuticals (Issuer)
Lurker Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
3:04 PM		Elston George (Reporting)
Eyepoint Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
3:04 PM		Eyepoint Pharmaceuticals (Issuer)
Ribeiro Ramiro (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
3:04 PM		DICICCO WENDY F (Reporting)
Eyepoint Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
3:04 PM		Duty Stuart (Reporting)
Eyepoint Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
3:04 PM		ANDO GORAN (Reporting)
Eyepoint Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
3:05 PM		Eyepoint Pharmaceuticals (Issuer)
Zaderej Karen L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
3:05 PM		Eyepoint Pharmaceuticals (Issuer)
Hassan Fred (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2024
6:05 AM		Eyepoint Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off (Ad)

Right now, we’re witnessing a monumental shift in the world.tc pixel

Our No. 1 AI Pick is currently trading for pennies on the dollar compared to Nividia.
11/14/2024
2:10 PM		Cormorant Asset Management, LP (Filed by)
Eyepoint Pharmaceuticals (Subject)
Form SC 13G/A
11/12/2024
1:31 PM		Eyepoint Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/12/2024
8:33 AM		Adage Capital Management, L.P. (Filed by)
Eyepoint Pharmaceuticals (Subject)
Form SC 13G/A
11/07/2024
6:05 AM		Eyepoint Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2024
7:54 AM		Eyepoint Pharmaceuticals (Subject)
FEDERATED HERMES, INC. (Filed by)
FEDERATED HERMES, INC. (Filed by)
Form SC 13G
11/04/2024
10:57 AM		Eyepoint Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
10/31/2024
3:16 PM		Eyepoint Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/31/2024
11:51 AM		Eyepoint Pharmaceuticals (Subject)
FRANKLIN RESOURCES INC (Filed by)
Form SCHEDULE 13G/A
10/30/2024
3:20 PM		Eyepoint Pharmaceuticals (Filer)
Form 424B5
10/28/2024
4:17 PM		Eyepoint Pharmaceuticals (Filer)
Form 424B5
10/28/2024
6:05 AM		Eyepoint Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/24/2024
6:05 AM		Eyepoint Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/23/2024
3:34 PM		ADAMIS ANTHONY P (Reporting)
Eyepoint Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/22/2024
2:24 PM		BlackRock, Inc. (Filed by)
Eyepoint Pharmaceuticals (Subject)
Form SC 13G
10/15/2024
10:58 AM		Eyepoint Pharmaceuticals (Subject)
GUYER DAVID R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/05/2024
3:02 PM		Eyepoint Pharmaceuticals (Issuer)
Hassan Fred (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
3:02 PM		Eyepoint Pharmaceuticals (Issuer)
Hassan Fred (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/04/2024
6:05 AM		Eyepoint Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:EYPT) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners
Musk’s Project Colossus could mint millionaires
I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...
Brownstone Research | Sponsoredtc pixel
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsoredtc pixel
BONUS GUIDE - Ben Stein Prepares For the Next Financial Crisis
With inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...
Goldco Precious Metals | Sponsoredtc pixel
This is my Christian duty
“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...
Paradigm Press | Sponsoredtc pixel
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...
Timothy Sykes | Sponsoredtc pixel
Alex’s “Next Magnificent Seven” stocks
The original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...
The Oxford Club | Sponsoredtc pixel
Elon’s Secret Social Security Bombshell
To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...
Banyan Hill Publishing | Sponsoredtc pixel
“Fed Proof” Your Bank Account with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank ac...
Weiss Ratings | Sponsoredtc pixel